Clinical trial
Treatment of Secondary Hyperparathyroidism in the Uremic Patient
NCT00469599 · Zealand University Hospital, Other · Terminated
Key facts
| NCT number | NCT00469599 |
|---|---|
| Title | Treatment of Secondary Hyperparathyroidism in the Uremic Patient |
| Official title | Treatment of Secondary Hyperparathyroidism in the Uremic Patient. A Study Comparing Alfacalcidol and Paricalcitol |
| Lead sponsor | Zealand University Hospital, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism, Chronic Kidney Disease, Vitamin D Deficiency |
| Intervention type | Drug |
| Interventions | paricalcitol, alfacalcidol |
| Enrollment | 86 |
| Start date | Jul 1, 2007 |
| Primary completion | Sep 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | May 4, 2007 |
| Last update posted | Apr 4, 2011 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: